Assessment of a novel VEGF targeted agent using patient-derived tumor tissue xenograft models of colon carcinoma with lymphatic and hepatic metastases
about
Patient-derived xenograft models of colorectal cancer in pre-clinical research: a systematic reviewOne mouse, one patient paradigm: New avatars of personalized cancer therapyThe future of patient-derived tumor xenografts in cancer treatment.Current status and perspectives of patient-derived xenograft models in cancer research.An ensemble prognostic model for colorectal cancer.Phenotypic and transcriptional fidelity of patient-derived colon cancer xenografts in immune-deficient miceLuteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancerProfile of conbercept in the treatment of neovascular age-related macular degeneration.Establishment of patient-derived cancer xenografts in immunodeficient NOG mice.Application of peptide displaying phage as a novel diagnostic probe for human lung adenocarcinoma.Antitumor effect of FP3 in a breast cancer xenograft model.Characterization of the Tumor-Microenvironment in Patient-Derived Cervix Xenografts (OCICx)Colon cancers carrying BRAF V600E and β-catenin T41A activating mutations are resistant to numerous common anticancer drugs.Development and characterization of a bladder cancer xenograft model using patient-derived tumor tissue.Antitumor effects of FP3 in combination with capecitabine on PDTT xenograft models of primary colon carcinoma and related lymphatic and hepatic metastases.
P2860
Q26741651-99F3FBF2-8946-48C1-9B54-E31604CBE1E7Q27023342-A862A7A2-47C5-45E9-B217-8FCDB3E97F81Q33361578-6D736897-EC00-4B9F-AEFB-9DC6561F02E9Q33667686-3A3B34BB-A8F8-4BE0-924A-117ED57FF8ABQ34713253-09C49FF4-08B6-419C-AE78-68DC3C8B341AQ35053317-8D3FBF8B-5F7F-4488-99D1-E5E256102756Q35060660-A83D7362-00B4-430A-A432-D0507034B761Q35541714-C852375B-1296-48DB-9C47-7748BC1A8085Q35798580-93229D39-EF9D-4C62-A944-9C12EEF21165Q35892258-45931F59-1314-48FC-AF31-61E63FD44D2CQ36472412-A50E2762-DEE7-402C-AFFF-58F8D71ADE48Q37017045-6852EF3F-73AF-4C68-8016-4E60E9CE0BCEQ52655145-AD3B0FC7-EA10-4C79-A897-5AEBF18963F8Q53342271-045B193B-1DCB-4887-B1B6-192E0DD5C349Q54509368-3758E446-C068-4CEC-9C7A-7B5AF53FF2E1
P2860
Assessment of a novel VEGF targeted agent using patient-derived tumor tissue xenograft models of colon carcinoma with lymphatic and hepatic metastases
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Assessment of a novel VEGF tar ...... mphatic and hepatic metastases
@ast
Assessment of a novel VEGF tar ...... mphatic and hepatic metastases
@en
Assessment of a novel VEGF tar ...... mphatic and hepatic metastases
@nl
type
label
Assessment of a novel VEGF tar ...... mphatic and hepatic metastases
@ast
Assessment of a novel VEGF tar ...... mphatic and hepatic metastases
@en
Assessment of a novel VEGF tar ...... mphatic and hepatic metastases
@nl
prefLabel
Assessment of a novel VEGF tar ...... mphatic and hepatic metastases
@ast
Assessment of a novel VEGF tar ...... mphatic and hepatic metastases
@en
Assessment of a novel VEGF tar ...... mphatic and hepatic metastases
@nl
P2093
P2860
P1433
P1476
Assessment of a novel VEGF tar ...... mphatic and hepatic metastases
@en
P2093
Binbin Cui
Bojian Xie
Feilin Cao
Guangliang Li
Haohao Wang
Huanrong Lan
Jing Zhang
Kuifeng He
Lisong Teng
P2860
P304
P356
10.1371/JOURNAL.PONE.0028384
P407
P577
2011-01-01T00:00:00Z